BPSG
ABBV icon

Brookfield Public Securities Group’s AbbVie ABBV Stock Holding History

Brookfield Public Securities Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1
Closed – – 145
2019
Q3 		$0 Buy
+1
New +$69 ﹤0.01% 184

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Brookfield Public Securities Group's ABBV Position: Q4 2019 in Review

Brookfield Public Securities Group sold out of AbbVie (ABBV) in Q4 2019, closing a stake of 1 share.

Brookfield Public Securities Group first reported a position in ABBV in Q3 2019 and held it in 1 quarter. The position peaked at $0 in Q3 2019. 2,243 funds tracked by Wall St. Rank hold ABBV as of Q4 2019.

  • Brookfield Public Securities Group reported no remaining AbbVie position as of Q4 2019 after selling out during the quarter.
  • Brookfield Public Securities Group sold 1 AbbVie share in Q4 2019.
  • Brookfield Public Securities Group first reported a position in AbbVie in Q3 2019 and held it in 1 quarter.
  • Brookfield Public Securities Group's AbbVie position peaked at $0 in Q3 2019.
  • 2,243 funds tracked by Wall St. Rank held AbbVie as of Q4 2019.

Based on Brookfield Public Securities Group's 13F filing for Q4 2019, filed 14 Feb 2020.